Dr. Redjal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3 Cooper Plz
Rm 104
Camden, NJ 08103Phone+1 856-342-3159Fax+1 732-790-0107
Education & Training
Massachusetts General HospitalResidency, Neurological Surgery, 2008 - 2015- Massachusetts General HospitalInternship, Surgery, 2008 - 2009
Harvard Medical SchoolClass of 2008
Certifications & Licensure
CA State Medical License 2015 - 2025
NJ State Medical License 2017 - 2025
PA State Medical License 2020 - 2022- American Board of Neurological Surgery Neurological Surgery
Clinical Trials
- Observation or Radiation Therapy in Treating Patients With Newly Diagnosed Grade II Meningioma That Has Been Completely Removed by Surgery Start of enrollment: 2017 Jun 14
- 3D Prediction of Patient-Specific Response Start of enrollment: 2018 Jun 11
- A Study Testing the Effect of Immunotherapy (Ipilimumab and Nivolumab) in Patients With Recurrent Glioma With Elevated Mutational Burden Start of enrollment: 2020 Dec 24
Publications & Presentations
PubMed
- Functional prediction of response to therapy prior to therapeutic intervention is associated with improved survival in patients with high-grade glioma.Aubrey Ledford, Analiz Rodriguez, Lindsay Lipinski, Ajay Abad, Robert Fenstermaker
Scientific Reports. 2024-08-29 - 5 citationsSingle-cell analysis reveals diversity of tumor-associated macrophages and their interactions with T lymphocytes in glioblastoma.Sai Batchu, Khalid A Hanafy, Navid Redjal, Saniya S Godil, Ajith J Thomas
Scientific Reports. 2023-11-27 - Cushing's Disease Associated With Partially Empty Sella Turcica Syndrome: A Case Report.Tehmina Habib, Mohammad Abu-Abaa, Navid Redjal
Cureus. 2023-06-01
Press Mentions
Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 6th, 2021
KIYATEC Announces Addition of Capital Health as Clinical Site in Trial to Predict GBM Patient-Specific Response to Cancer Drugs Prior to TreatmentAugust 13th, 2019
Center for Neuro-Oncology Leads New Brain Tumor Guidelines Paper and Advances Participation in Immunotherapy Trials for Glioblastoma PatientsApril 8th, 2021- Join now to see all
Professional Memberships
- Member
- Fellow
- Society of Neuro-oncologyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
